|
Market Closed -
Toronto S.E.
23:35:56 10/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4500 CAD | -2.17% |
|
-4.26% | -1.10% |
| 08-27 | Pharmacorp Rx Inc. Announces Board and Committee Changes, Effective from August 31, 2026 | CI |
| 08-20 | PharmaCorp Rx Swings to Q2 Profit as Revenue Jumps | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 46x | - | -0.23x | 1.71x | 21.34x | 50.08x | - | 56.69M | ||
| 16.08x | 1.45x | 1.55x | 0.63x | 9.38x | 10.21x | -.--% | 14.09B | ||
| 16.37x | 1.69x | 1.57x | 0.73x | 7.65x | 9.59x | 2.27% | 6.36B | ||
| 20.28x | 2.25x | 2.64x | 0.76x | 12.85x | 13.09x | 1.1% | 6.19B | ||
| 14.64x | 2.17x | 1.01x | 0.9x | 6.2x | 8.44x | 2.87% | 4.1B | ||
| 14.45x | 4.38x | 24.15x | 1.24x | 7.59x | 14.23x | 5.57% | 3.17B | ||
| 14.02x | 2.65x | 0.68x | 0.59x | 4.57x | 7.52x | 5.15% | 3.05B | ||
| 13.24x | 5.94x | 2.31x | 0.79x | 5.91x | 8.22x | 4.91% | 2.81B | ||
| 35.35x | - | 0.62x | - | - | - | - | 2.78B | ||
| 18.59x | 3.25x | 0.81x | 0.55x | 7.09x | 11.61x | 2.18% | 1.37B | ||
| -108.76x | 2.25x | 1.47x | 0.38x | 13.78x | 49.67x | 0.02% | 1.31B | ||
| 14.37x | 0.87x | 0.2x | 0.3x | 2.79x | 7.16x | 3.2% | 948M | ||
| 20.59x | 2.42x | -0.41x | 0.83x | 7.66x | 18.22x | 6% | 877M | ||
| 39.18x | 3.74x | -6.02x | 0.91x | 11.4x | 22.45x | - | 827M | ||
| 27.17x | 7.41x | 1x | 0.98x | 13.41x | 20.79x | 1.32% | 799M | ||
| Average | 13.44x | 3.11x | 2.09x | 0.81x | 9.40x | 17.95x | 2.88% | 3.25B | |
| Weighted average by Cap. | 14.59x | 2.44x | 2.83x | 0.74x | 8.68x | 12.04x | 2.05% |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















